Adenocarcinoma of the lung diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sudarshana Datta, MD [2]

Adenocarcinoma of the Lung Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Adenocarcinoma of the Lung from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
Staging
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
Echocardiography and Ultrasound
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Intervention
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Adenocarcinoma of the lung diagnostic study of choice On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Adenocarcinoma of the lung diagnostic study of choice All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Adenocarcinoma of the lung diagnostic study of choice
CDC on Adenocarcinoma of the lung diagnostic study of choice
Adenocarcinoma of the lung diagnostic study of choice in the news
Blogs on Adenocarcinoma of the lung diagnostic study of choice
Directions to Hospitals Treating Adenocarcinoma of the lung
Risk calculators and risk factors for Adenocarcinoma of the lung diagnostic study of choice

Overview

Biopsy is the diagnostic study of choice for adenocarcinoma of the lung. On microscopic histopathological analysis, nuclear atypia, eccentrically placed nuclei, abundant cytoplasm, and conspicuous nucleoli are characteristic findings of adenocarcinoma of the lung. Atypical adenomatous hyperplasia (AAH) is the precursor of peripheral adenocarcinomas. It consists of well demarcated columnar or cuboidal cells with varying degrees of cytologic atypia, hyperchromasia, pleomorphism and prominent nucleoli.

Diagnostic Study of Choice

• Biopsy is helpful in the diagnosis of adenocarcinoma of the lung.
  • Fine needle aspiration (FNA):
    • CT guided FNA uses a small amount of tissue from a suspected lung tumor or from a lymph node in the chest.
    • FNA may also be obtained during bronchoscopy, along with endobronchial ultrasound, to take samples of lymph nodes around the trachea and bronchi.

• Thoracentesis
  • Thoracentesis may be done to remove fluid from around the lungs to see if it contains cancer cells.
• On microscopic histopathological analysis, nuclear atypia, eccentrically placed nuclei, abundant cytoplasm, and conspicuous nucleoli are characteristic findings of adenocarcinoma of the lung.
• Atypical adenomatous hyperplasia (AAH): is the precursor of peripheral adenocarcinomas. It consists of well demarcated columnar or cuboidal cells with the following features:
  • Varying degrees of cytologic atypia
  • Hyperchromasia
  • Pleomorphism
  • Prominent nucleoli
• As adenocarcinoma is a derivative of mucus producing glands in the lungs, it tends to stain mucin positive.
• Based on differentiation, the tumor may be:
  • Well differentiated (low grade): Normal appearance
  • Poorly differentiated (high grade): Abnormal glandular appearance with a positive mucin stain
• Subtypes
  • Lepidic predominant:

  • Tumor grows long the alveolar wall

  • Acinar predominant:

  • Berry-shaped glands, smaller than lung acini

  • Papillary predominant:

  • Fibrovascular cores

  • Micropapillary predominant:

  • Nipple shaped projections without fibrovascular cores

  • Solid predominant:

  • Sheet of cells